SEC Form 4 · accession 0001144204-16-097824
NAVIDEA BIOPHARMACEUTICALS, INC. · NAVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric K Rowinsky
Director
Period of report
Apr 8, 2016
Accepted (ET)
Apr 29, 2016 · 4:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000810509
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 8, 2016 | A | 10,726 | $1.14 | A | 196,446 | D | |
| Common StockF2 | Apr 20, 2016 | A | 28,000 | $0.00 | A | 224,446 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Acquired from Issuer in lieu of cash compensation for board services during first quarter of 2016.
- F2Restricted Shares granted pursuant to the Issuer's 2014 Amended and Restated Stock Incentive Plan which vest on the one year anniversary of the date of grant.
Remarks
Exhibit Index - Exhibit 24 - Power of Attorney